ANGELIC WASHINGTON: Open Payments
NPI 1588294243 · GREENVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$856 in 45 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $337 · 2025 $856
Food & beverage: $856
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $206 |
| ABBVIE INC. | 9 | $150 |
| Lundbeck LLC | 3 | $67 |
| Janssen Pharmaceuticals, Inc | 3 | $62 |
| Biogen, Inc. | 2 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Supernus Pharmaceuticals, Inc. | 2 | $40 |
| Neos Therapeutics, LP | 2 | $39 |
Products named: REXULTI, VRAYLAR, SPRAVATO, ZURZUVAE, CAPLYTA, HETLIOZ, AUSTEDO XR, Qelbree.
Industry payments across OH — which companies pay providers there.
